InnoVoyce

InnoVoyce develops advanced solid-state laser technologies for the prevention, diagnosis, and treatment of voice disorders and ENT procedures. The company manufactures the VYLO™ 455nm blue light surgical laser system, engineered for precision soft tissue surgery with up to 30 watts of power and multiple operational modes. InnoVoyce also produces FDA-cleared laser fibers (0.3mm, 0.4mm, 0.6mm diameters) and surgical accessories designed to enhance procedural precision and patient outcomes. Founded through collaboration with Harvard Medical and the Voice Health Institute, InnoVoyce addresses the clinical needs of millions with voice pathologies, offering versatile solutions for laryngeal procedures, voice health restoration, and broader ENT applications. The company maintains active participation in major otolaryngology and head-neck surgery conferences, with ongoing research and development in biomaterials and laser fiber innovation.